CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancerErin M. Bange, John P. Reilly, Nicholas Han et al.|Nature Medicine|2021Cited by 519
BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriersKara N. Maxwell, Katherine L. Nathanson|Nature Communications|2017Cited by 308
NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024Mary B. Daly, Susan Darlow, Michael Goggins et al.|Journal of the National Comprehensive Cancer Network|2023Cited by 284
The relationship between circulating lipids and breast cancer risk: A Mendelian randomization studyKelsey E. Johnson, Benjamin F. Voight, Katherine M. Siewert et al.|PLoS Medicine|2020Cited by 131
Genomic Signatures Predict the Immunogenicity of BRCA-Deficient Breast CancerAdam Kraya, Katherine L. Nathanson, Kara N. Maxwell et al.|Clinical Cancer Research|2019Cited by 103